- 《Drug Delivery & Translational Research》 被引量: 0发表: 2024年 Developing nanosize carrier systems for Amphotericin‐B: A review on the biomedical application of nanoparticles for the treatment of leishmaniasis and fun... New formulations of Amphotericin‐B (Am‐B), the most popular ...
27,37 Of note, M2-like microglia and macrophage cells are more resistant to the treatment, therefore, their repolarization or reprogramming may result in a significant improvement in GBM prognosis and inhibition of tumour progression.39 Figure 2 visualises the relation between the...
The latter is one of the newest diagnostic tools being used to define those patients that may respond best to treatment. All of these proteins identified in my research as being affected by mAR activation are considered of extreme importance in GBM pathology. This coupled with the results ...
research team, the proposed NK-92/5.28.z cell therapy has shown a promising synergistic effect when combined with PD-1 checkpoint inhibition in murine models.181,182 This combina- torial approach enhanced the cytotoxic CAR-NK effect and enabled the treatment of gliomas refractory to the mono- ...